Cardinal Health, Inc. $CAH Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC grew its position in Cardinal Health, Inc. (NYSE:CAH) by 0.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,529,013 shares of the company’s stock after acquiring an additional 43,924 shares during the period. Geode Capital Management LLC’s holdings in Cardinal Health were worth $1,336,750,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of CAH. Integrated Wealth Concepts LLC raised its position in shares of Cardinal Health by 6.9% in the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after acquiring an additional 280 shares during the period. Jones Financial Companies Lllp raised its position in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares during the period. Arrowstreet Capital Limited Partnership acquired a new position in shares of Cardinal Health during the 2nd quarter worth about $1,935,000. Cerity Partners LLC raised its position in shares of Cardinal Health by 17.0% during the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock worth $6,792,000 after purchasing an additional 5,880 shares during the last quarter. Finally, Nebula Research & Development LLC raised its position in shares of Cardinal Health by 34.4% during the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock worth $1,736,000 after purchasing an additional 2,646 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.2%

CAH stock opened at $199.53 on Friday. The company has a market cap of $46.73 billion, a price-to-earnings ratio of 30.51, a PEG ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $233.60. The firm has a 50-day moving average of $203.82 and a two-hundred day moving average of $208.88.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 31.19%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CAH. Wells Fargo & Company reduced their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Zacks Research upgraded shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. Mizuho upped their price target on shares of Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a research report on Friday, February 6th. Evercore reduced their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. Finally, Robert W. Baird set a $248.00 price target on shares of Cardinal Health in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.